Showing results (81-90 of 129) with videos related to
Sort By:
Pageof 13
Translational Oncology|December 30, 2018
Oncologic Outcomes in Metastatic Colorectal Cancer with Regorafenib with FOLFIRI as a Third- or Fourth-Line SettingCheng-Jen Ma, Ching-Wen Huang, Tsung-Kun Chang, et al.Aging Cell|June 8, 2021
Senolytics alleviate the degenerative disorders of temporomandibular joint in old ageYueying Zhou, Iman M A Al-Naggar, Po-Jung Chen, et al.Cells|December 11, 2022
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon CancerJen-Pin Chuang, Hsiang-Lin Tsai, Po-Jung Chen, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|July 8, 2021
The feasibility of an approximate irregular field dose distribution simulation program applied to a respiratory motion compensation systemLai-Lei Ting, Ai-Ho Liao, Muthusankar Ganesan, et al.International Journal of Environmental Research and Public Health|October 23, 2021
Sunlight Exposure and Phototherapy: Perspectives for Healthy Aging in an Era of COVID-19Toshiaki Nakano, Kuei-Chen Chiang, Chien-Chih Chen, et al.Oncology Research|February 18, 2022
Comparison of <i>UGT1A1</i> Polymorphism as Guidance of Irinotecan Dose Escalation in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line TherapyHsiang-Lin Tsai, Yen-Cheng Chen, Tzu-Chieh Yin, et al.Surgical Endoscopy|October 21, 2024
Innovative needle-assisted technique for intracorporeal anastomosis: Simplifying closure of common enterotomy in laparoscopic gastrointestinal surgeryTzu-Chieh Yin, Yen-Cheng Chen, Wei-Chih Su, et al.The Journal of International Medical Research|July 13, 2022
Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous <i>UGT1A1*28</i> polymorphism: a single-center case seriesHsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, et al.Oncology Letters|April 25, 2025
Effects of first‑line therapies in patients with locally advanced gastrointestinal stromal tumors with <i>KIT</i> and <i>PDGFRα</i> gene mutations: A single‑center studyWei-Chih Su, Ching-Wen Huang, Yen-Cheng Chen, et al.Integrative Cancer Therapies|October 12, 2023
The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled StudyHsiang-Lin Tsai, Yung-Sung Yeh, Po-Jung Chen, et al.Pageof 13